IRF1 cooperates with ISGF3 or GAF to form innate immune de novo enhancers in macrophages
Science Signaling · 2025
DOI: 10.1126/scisignal.ado8860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Carolina Chavez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Medical Pharmacology PhD Program, UCLA, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-1, Macrophages, Immunity, Innate. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Macrophages exposed to immune stimuli reprogram their epigenomes to alter their subsequent functions. Exposure to bacterial lipopolysaccharide (LPS) causes widespread nucleosome remodeling and the formation of thousands of de novo enhancers. We dissected the regulatory logic by which the network of interferon regulatory factors (IRFs) induces the opening of chromatin and the formation of de novo enhancers. We found that LPS-activated IRF3 mediated de novo enhancer formation indirectly by activating the type I interferon (IFN)–induced ISGF3. However, ISGF3 was generally needed to collaborate with IRF1, particularly where chromatin was less accessible. At these locations, IRF1 was required for the initial opening of chromatin, with ISGF3 extending accessibility and promoting the deposition of H3K4me1, marking poised enhancers. Because IRF1 expression depends on the transcription factor NF-κB, which is activated in infected but not bystander cells, IRF-regulated enhancers required activation of both the IRF3 and NF-κB branches of the innate immune signaling network. However, type II IFN (IFN-γ), which is typically produced by T cells, may also induce IRF1 expression through the STAT1 homodimer GAF. We showed that, upon IFN-γ stimulation, IRF1 was also responsible for opening inaccessible chromatin sites that could then be exploited by GAF to form de novo enhancers. Together, our results reveal how combinatorial logic gates of IRF1-ISGF3 or IRF1-GAF restrict immune epigenomic memory formation to macrophages exposed to pathogens or IFN-γ–secreting T cells but not bystander macrophages exposed transiently to type I IFN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular and Medical Pharmacology PhD Program, UCLA, Los Angeles, CA, USA.
- Department of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, CA, USA.
- Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
- Molecular Biology PhD Program, UCLA, Los Angeles, CA, USA.
ORCID-Profile: Kelly Lin, Aleksandr Gorin, Quen J Cheng, Alexander Hoffmann
Förderung
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Chavez, C., Lin, K., Malveaux, A., Gorin, A., Brizuela, S., Cheng, Q. J., & Hoffmann, A. (2025). IRF1 cooperates with ISGF3 or GAF to form innate immune de novo enhancers in macrophages. Science Signaling. https://doi.org/10.1126/scisignal.ado8860
Vancouver
Chavez C, Lin K, Malveaux A, Gorin A, Brizuela S, Cheng QJ, et al. IRF1 cooperates with ISGF3 or GAF to form innate immune de novo enhancers in macrophages. Science Signaling. 2025. doi:10.1126/scisignal.ado8860
BibTeX
@article{Chavez2025,
author = {Chavez, Carolina and Lin, Kelly and Malveaux, Alexis and Gorin, Aleksandr and Brizuela, Stefanie and Cheng, Quen J and Hoffmann, Alexander},
title = {IRF1 cooperates with ISGF3 or GAF to form innate immune de novo enhancers in macrophages},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.ado8860}
}
EUVIMED